Drug Type Antibody toxin conjugate |
Synonyms Anti-Mesothelin Immunotoxin, CAT 5001, SS 1P + [1] |
Target |
Action inhibitors |
Mechanism MSLN inhibitors(Mesothelin inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adenocarcinoma of Lung | Phase 2 | United States | 11 May 2011 | |
Advanced Lung Adenocarcinoma | Phase 2 | United States | 11 May 2011 | |
Malignant Mesothelioma of Peritoneum | Phase 2 | United States | 11 May 2011 | |
Malignant Pleural Mesothelioma | Phase 2 | United States | 11 May 2011 | |
Pancreatic adenocarcinoma | Phase 2 | United States | 11 May 2011 | |
Mesothelioma | Phase 2 | - | - | |
Ovarian Cancer | Phase 2 | - | - | |
Ovarian Cancer | Phase 2 | - | - | |
Pancreatic Cancer | Phase 2 | - | - | |
Unresectable Lung Non-Small Cell Carcinoma | Phase 1 | United States | 29 Dec 2009 |
Not Applicable | 11 | nsypqzajub(vqwckxdyel) = naimtzsowk fbalnpfhgr (uswjyiiwjw, +) View more | - | 29 Oct 2013 | |||
nsypqzajub(vqwckxdyel) = wglewnwflk fbalnpfhgr (uswjyiiwjw, +) View more | |||||||
Not Applicable | - | eurfkxkvos(vwltjvhgww) = bixrtntlwr lgtxzxicel (qvowrxkdkk ) | Positive | 20 May 2011 | |||
Phase 1 | 34 | pebalplenf(ijnqvdvoqq) = aevxkvtipv vhgzgbtpkp (nrymfkvbzn ) View more | - | 20 Jun 2007 |